Lundbeck to present new data on Bexicaserin for developmental and epileptic encephalopathies and Eptinezumab in migraine at AAN 2025
H. Lundbeck A/S (Lundbeck) announced that recent pipeline data will be presented at the 2025 AAN Annual Meeting in San Diego, U.S. The data includes an oral presentation… read more.
